HAVCR2 and neoplasm: Recent studies show that tumor-infiltrating Tregs can induce much higher expression of many immune checkpoint molecules such as LAG-3, TIM-3, GITR, CTLA-4 and PD-1, making them feasible targets for ICPI [32].